Medline Inc (MDLN) Gross Profit Margin starting from the third quarter 2026 to third quarter 2025, Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Medline Inc   (NASDAQ: MDLN)


Medline Inc 's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

MDLN Gross Profit Margin (Sep 26 2026)
Q3 		(Jun 27 2026)
Q2 		(Mar 28 2026)
Q1 		(Dec 31 2025)
Q4 		(Sep 27 2025)
Q3
Y / Y Revenue Change 10.41 %
Seq. Revenue Change 2.23 %
Revenue In Millions $7,856.00
Gross Profit Margin 24.5 %
Gross Profit Margin Total Ranking # 2722
Gross Profit In Millions $1,925.00
Y / Y Gross Profit Change 2.67 %
Seq. Gross Profit Change -13.09 %


Commenting Third Quarter 2026 Gross Profit Margin
Company's Gross Profit Margin sequentially deteriorated to 24.5 % due to increase in Cost of Sales and despite Revenue increase of 2.23 % to $7,856 millions.
Medline Inc achieved highest Gross Profit Margin in III. Quarter


Observing third quarter 2026 results within Medical Equipment & Supplies industry 155 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin total ranking has impoved so far to 2722, from total ranking in the previous quarter at 2988.
Learn about Gross Margin
MDLN's Gross Profit Margin third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 156
Healthcare Sector # 401
Overall # 2700

Gross Profit Margin Statistics
High Average Low
28.82 % 26.35 % 24.5 %
(Jun 27 2026)   (Sep 26 2026)


MDLN Gross Income Trends • More of MDLN's Profitabilty Ratios • MDLN Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
MDLN's Cumulative Gross Profit Margin
Medical Equipment & Supplies Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
MDLN's Gross Profit Margin Profitability versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for MDLN's Competitors
Gross Profit Margin Profit Margin for Medline Inc 's Suppliers
Gross Profit Margin Profit Margin for MDLN's Customers

You may also want to know
MDLN's Annual Growth Rates MDLN's Profitability Ratios MDLN's Asset Turnover Ratio MDLN's Dividend Growth
MDLN's Roe MDLN's Valuation Ratios MDLN's Financial Strength Ratios MDLN's Gross Profit Growth
MDLN's Roa MDLN's Inventory Turnover Ratio MDLN's Growth Rates MDLN's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Sep 26 2026, within Medical Equipment & Supplies Industry Gross Profit MarginSep 26 2026 MRQ Gross ProfitSep 26 2026 MRQ Revenue
Boston Scientific Corporation  66.72 %$ 3,428.000  Millions$ 5,138.000  Millions
Procept Biorobotics Corporation  66.28 %$ 65.148  Millions$ 98.291  Millions
Stryker Corp  65.15 %$ 4,248.000  Millions$ 6,520.000  Millions
Teleflex Incorporated  64.95 %$ 368.788  Millions$ 567.783  Millions
Dexcom Inc   64.29 %$ 864.400  Millions$ 1,344.500  Millions
Apyx Medical Corp  64.16 %$ 9.001  Millions$ 14.030  Millions
Sintx Technologies Inc   62.19 %$ 1.362  Millions$ 2.190  Millions
Haemonetics Corporation  61.75 %$ 220.913  Millions$ 357.759  Millions
Anika Therapeutics Inc   61.57 %$ 18.837  Millions$ 30.594  Millions
Enovis Corp  61.43 %$ 348.547  Millions$ 567.425  Millions
Resmed Inc   60.38 %$ 870.567  Millions$ 1,441.814  Millions
Angiodynamics Inc   59.37 %$ 48.040  Millions$ 80.915  Millions
Clearpoint Neuro Inc   58.46 %$ 7.059  Millions$ 12.075  Millions
Transmedics Group Inc   58.45 %$ 118.657  Millions$ 203.005  Millions
Nephros Inc   58.45 %$ 3.286  Millions$ 5.622  Millions
Envista Holdings Corporation  57.93 %$ 400.600  Millions$ 691.500  Millions
Beta Bionics Inc   57.26 %$ 20.331  Millions$ 35.505  Millions
Tandem Diabetes Care Inc   56.55 %$ 160.422  Millions$ 283.690  Millions
Conmed Corporation  56.37 %$ 189.148  Millions$ 335.557  Millions
Solventum Corporation  54.49 %$ 1,062.000  Millions$ 1,949.000  Millions
Warby Parker Inc   54.41 %$ 133.171  Millions$ 244.735  Millions
Dentsply Sirona Inc   52.99 %$ 443.000  Millions$ 836.000  Millions
Neuronetics Inc   52.28 %$ 21.990  Millions$ 42.062  Millions
Pulse Biosciences Inc   51.65 %$ 0.204  Millions$ 0.395  Millions
Edap Tms Sa  51.40 %$ 5.052  Millions$ 9.828  Millions
Integra Lifesciences Holdings Corp  51.04 %$ 209.866  Millions$ 411.182  Millions
Medinotec Inc   48.74 %$ 1.560  Millions$ 3.201  Millions
Merit Medical Systems Inc  48.20 %$ 200.631  Millions$ 416.244  Millions
Msa Safety Inc  45.53 %$ 244.231  Millions$ 536.430  Millions
Steris Plc  44.74 %$ 710.800  Millions$ 1,588.600  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.